In recognition of National Cancer Survivors Month this June, the Colorectal Cancer Alliance (Alliance) is shining a light on the more than 1.5 million colorectal cancer survivors in the United States, celebrating their strength while calling attention to increasing rates of colorectal cancer and the urgent need for more screening and research to end the disease.
New data from the Alliance’s 2025 State of Screening Study reveals that a majority of Americans prioritize household chores over colorectal cancer screening, putting their lives at risk. The survey also shows that many Americans are unaware that the disease could be prevented through screening. Colorectal cancer is the second leading cause of cancer-related deaths in the U.S., yet when detected early, the five-year survival rate exceeds 90%. The Alliance’s State of Screening Study underscores the life-saving potential of increased awareness and access to screening, especially as cases continue to rise in younger adults.
Among key findings from the 2025 Colorectal Cancer State of Screening Study:
“Screening saves lives—it's that simple,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance. “This June, we're asking people to honor survivors by taking action: get screened, talk to your loved ones, and help others do the same.”
The Alliance encourages the public to participate this June by:
Research is critical to progress in the battle against colorectal cancer. Through Project Cure CRC, the Alliance is committed to funding cutting-edge research and amplifying BlueHQ, its dynamic patient portal, with enhanced data collection and clinical trial protocols to improve survivorship.
To learn more about screening visit getscreened.org, and to learn more or support Project Cure CRC visit colorectalcancer.org/cure.
About the Colorectal Cancer Alliance
The Colorectal Cancer Alliance empowers a nation of passionate and determined allies to prevent, treat, and overcome colorectal cancer in their lives and communities. Founded in 1999 and headquartered in Washington, D.C., the Alliance advocates for prevention through initiatives like LEAD FROM BEHIND, magnifies support with BlueHQ, and accelerates research through Project Cure CRC. We are the largest national nonprofit dedicated to colorectal cancer, and we exist to end this disease in our lifetime. For more information, visit colorectalcancer.org.
Media Contact:
Emily Blasi
eblasi@ccalliance.org
(202) 971-9964
A first-of-its-kind trial platform in the colorectal cancer space, Project Cure CRC’s KLEOS is being driven by the Colorectal Cancer Alliance, the leading nonprofit dedicated to ending the disease, in collaboration with GCAR, a pioneer in the design and implementation of innovative clinical trials.
As the nation observes Women's Health Month (beginning on Mother's Day) and Clinical Trials Awareness Month, the leading nonprofit Colorectal Cancer Alliance (Alliance) is calling on patients, caregivers, and healthcare providers to confront the urgent and underrecognized public health challenges that may be contributing to the rising death rates.
Asal Sayas, a force for good in public policy and a champion for patients, who worked for both a president and a senator, died Tuesday, April 21, after a defiant six-year path with young-onset colorectal cancer. She was 42 years old.